WHO launches first trial of antiviral to prevent Bundibugyo strain of Ebola
The World Health Organization launched the first clinical trial on Tuesday to test whether an antiviral drug can prevent infection in people exposed to the Bundibugyo strain of Ebola in the Democratic Republic of Congo, as the outbreak continues to outpace response efforts and spread beyond known chains of transmission.
Black News 
The World Health Organization launched the first clinical trial on Tuesday to test whether an antiviral drug can prevent infection in people exposed to the Bundibugyo strain of Ebola in the Democratic Republic of Congo, as the outbreak continues to outpace response efforts and spread beyond known chains of transmission.
